拮抗剂-话题@MedSci

#拮抗剂#

223篇内容 | 1646人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2164573, encodeId=802e21645e312, content=<a href='/topic/show?id=e01f3e12825' target=_blank style='color:#2F92EE;'>#原发性醛固酮增多症#</a>(PA)是一种常见但常被忽视的高血压病因，其特征是<a href='/topic/show?id=f4e88263259' target=_blank style='color:#2F92EE;'>#肾素#</a>不依赖自主<a href='/topic/show?id=ac549564240' target=_blank style='color:#2F92EE;'>#醛固酮#</a>分泌过多。大约30%的PA患者醛固酮分泌过多，即以肾上腺为主。在这些患者中，<a href='/topic/show?id=9c6d3612529' target=_blank style='color:#2F92EE;'>#单侧肾上腺切除#</a>术被认为是治疗的选择。对于双侧疾病的患者，建议使用矿物皮质激素受体<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>(MRA)进行药物治疗。, objectTitle=Hypertension：原发性醛固酮增多症患者的死亡率, objectType=article, longId=797582, objectId=77eae975826d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301024/1698105883674_1739456.jpg, objectUrl=/article/show_article.do?id=77eae975826d, replyNumber=0, likeNumber=34, createdTime=2023-10-24, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=77eae975826d, moduleTitle=Hypertension：原发性醛固酮增多症患者的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77eae975826d)], followStatus=false, userIsMember=true, type=1, lengthMark=1), GetTopicListResponse(id=1511819, encodeId=22a4151181948, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=常用血管紧张素受体拮抗剂解析, objectType=article, longId=738405, objectId=e212e3840564, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e212e3840564, replyNumber=0, likeNumber=40, createdTime=2022-09-08, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e212e3840564, moduleTitle=常用血管紧张素受体拮抗剂解析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e212e3840564)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511818, encodeId=3a391511818e9, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=PRS：半胱氨酸白三烯信号拮抗剂孟鲁司特不利于烧伤创面愈合, objectType=article, longId=737708, objectId=f1dbe377088c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1dbe377088c, replyNumber=0, likeNumber=59, createdTime=2022-09-04, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1dbe377088c, moduleTitle=PRS：半胱氨酸白三烯信号拮抗剂孟鲁司特不利于烧伤创面愈合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1dbe377088c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511817, encodeId=f936151181e5a, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Stroke：脑静脉血栓形成患者直接口服抗凝剂与维生素K拮抗剂的疗效比较, objectType=article, longId=735322, objectId=191fe35322e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=191fe35322e9, replyNumber=0, likeNumber=34, createdTime=2022-08-10, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=191fe35322e9, moduleTitle=Stroke：脑静脉血栓形成患者直接口服抗凝剂与维生素K拮抗剂的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=191fe35322e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511816, encodeId=ba3a1511816cd, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=盘点多巴胺受体拮抗剂在精神分裂症中的临床应用, objectType=article, longId=733228, objectId=f532e3322830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f532e3322830, replyNumber=0, likeNumber=54, createdTime=2022-07-27, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f532e3322830, moduleTitle=盘点多巴胺受体拮抗剂在精神分裂症中的临床应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f532e3322830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511815, encodeId=d89615118152c, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Eur Rev Med Pharmacol Sci：老年人创伤性脑损伤前服用VK拮抗剂或DOACs是否会影响其结局？, objectType=article, longId=732947, objectId=823ae3294744, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=823ae3294744, replyNumber=0, likeNumber=47, createdTime=2022-07-23, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=823ae3294744, moduleTitle=Eur Rev Med Pharmacol Sci：老年人创伤性脑损伤前服用VK拮抗剂或DOACs是否会影响其结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=823ae3294744)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511814, encodeId=ffa1151181465, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Lancet rheumatology：儿童多系统炎症综合征中针对白细胞介素-1受体拮抗剂的自身抗体：一项多中心、回顾性、队列研究, objectType=article, longId=727844, objectId=e580e278440f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e580e278440f, replyNumber=0, likeNumber=42, createdTime=2022-05-27, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e580e278440f, moduleTitle=Lancet rheumatology：儿童多系统炎症综合征中针对白细胞介素-1受体拮抗剂的自身抗体：一项多中心、回顾性、队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e580e278440f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511813, encodeId=c677151181300, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Cell：揭示使用药用大麻增加心脏病风险，CB1拮抗剂染料木黄酮有望来拯救, objectType=article, longId=727803, objectId=5730e278039e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5730e278039e, replyNumber=0, likeNumber=57, createdTime=2022-05-26, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5730e278039e, moduleTitle=Cell：揭示使用药用大麻增加心脏病风险，CB1拮抗剂染料木黄酮有望来拯救, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5730e278039e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511812, encodeId=8ea41511812e7, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JACC：盐皮质激素受体拮抗剂对恩格列净治疗射血分数保留的心衰患者的效果的影响, objectType=article, longId=301906, objectId=85dd3019062a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85dd3019062a, replyNumber=0, likeNumber=33, createdTime=2022-03-30, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85dd3019062a, moduleTitle=JACC：盐皮质激素受体拮抗剂对恩格列净治疗射血分数保留的心衰患者的效果的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85dd3019062a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511811, encodeId=4252151181133, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Neurology：神经结节病预后与病变定位相关，肿瘤坏死因子α拮抗剂优于单独使用皮质类固醇, objectType=article, longId=301043, objectId=5035301043dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5035301043dc, replyNumber=0, likeNumber=0, createdTime=2022-03-19, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5035301043dc, moduleTitle=Neurology：神经结节病预后与病变定位相关，肿瘤坏死因子α拮抗剂优于单独使用皮质类固醇, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5035301043dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511810, encodeId=3689151181032, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=失眠患者的福音，CHMP推荐双效食欲素受体拮抗剂Quviviq, objectType=article, longId=300369, objectId=43ec300369f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43ec300369f4, replyNumber=0, likeNumber=0, createdTime=2022-03-11, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43ec300369f4, moduleTitle=失眠患者的福音，CHMP推荐双效食欲素受体拮抗剂Quviviq, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43ec300369f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511809, encodeId=30581511809aa, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Eur Respir J：白细胞介素 6 受体拮抗剂对成年重症 COVID-19 肺炎患者的影响, objectType=article, longId=299886, objectId=b3e22998866b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3e22998866b, replyNumber=0, likeNumber=45, createdTime=2022-03-03, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3e22998866b, moduleTitle=Eur Respir J：白细胞介素 6 受体拮抗剂对成年重症 COVID-19 肺炎患者的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3e22998866b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511808, encodeId=3d971511808a2, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JAHA：绝经后妇女组胺H2受体拮抗剂与心力衰竭风险之间的关系, objectType=article, longId=299533, objectId=8d48299533ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d48299533ee, replyNumber=0, likeNumber=63, createdTime=2022-02-25, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d48299533ee, moduleTitle=JAHA：绝经后妇女组胺H2受体拮抗剂与心力衰竭风险之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d48299533ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511807, encodeId=3339151180eb6, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=亚太III期BHV3000-310研究显示，口服降钙素基因相关肽（CGRP）受体拮抗剂，可快速和持久地缓解偏头痛, objectType=article, longId=295705, objectId=74b3295e05cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74b3295e05cf, replyNumber=0, likeNumber=49, createdTime=2022-02-17, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74b3295e05cf, moduleTitle=亚太III期BHV3000-310研究显示，口服降钙素基因相关肽（CGRP）受体拮抗剂，可快速和持久地缓解偏头痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74b3295e05cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511806, encodeId=a6721511806cd, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=拜耳放弃研发P2X3受体拮抗剂eliapixant, objectType=article, longId=295169, objectId=7fe7295169ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fe7295169ea, replyNumber=0, likeNumber=50, createdTime=2022-02-07, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fe7295169ea, moduleTitle=拜耳放弃研发P2X3受体拮抗剂eliapixant, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fe7295169ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511805, encodeId=8a22151180552, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=CGH: 维多珠单抗与肿瘤坏死因子拮抗剂在炎症性肠病患者中造成严重感染风险的差异比较, objectType=article, longId=294779, objectId=9f42294e7942, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f42294e7942, replyNumber=0, likeNumber=46, createdTime=2022-01-28, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f42294e7942, moduleTitle=CGH: 维多珠单抗与肿瘤坏死因子拮抗剂在炎症性肠病患者中造成严重感染风险的差异比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f42294e7942)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511804, encodeId=5d8715118048e, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JACL:TRPV1拮抗剂Asivatrep用于局部治疗特应性皮炎, objectType=article, longId=292593, objectId=654d292593cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=654d292593cf, replyNumber=0, likeNumber=48, createdTime=2021-12-24, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=654d292593cf, moduleTitle=JACL:TRPV1拮抗剂Asivatrep用于局部治疗特应性皮炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=654d292593cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511803, encodeId=e19f1511803a4, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=新药进展 | 治疗慢性咳嗽！中国生物制药自研1类新药P2X3受体拮抗剂获批临床, objectType=article, longId=292525, objectId=566729252516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=566729252516, replyNumber=0, likeNumber=41, createdTime=2021-12-24, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=566729252516, moduleTitle=新药进展 | 治疗慢性咳嗽！中国生物制药自研1类新药P2X3受体拮抗剂获批临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=566729252516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511802, encodeId=8d6f151180200, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=NEJM：依度沙班对比维生素K拮抗剂治疗TAVR后房颤的疗效比较, objectType=article, longId=221433, objectId=288d221433d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=288d221433d2, replyNumber=0, likeNumber=37, createdTime=2021-12-03, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=288d221433d2, moduleTitle=NEJM：依度沙班对比维生素K拮抗剂治疗TAVR后房颤的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=288d221433d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511801, encodeId=5b9415118015d, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=J Clin Oncol：神经激肽-1受体拮抗剂fosnetupitant (FosNTP)对比fosaprepitant (FosAPR)预防高致吐性化疗引起的恶心和呕吐的有效性和安全性, objectType=article, longId=220833, objectId=ff7e22083386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff7e22083386, replyNumber=0, likeNumber=36, createdTime=2021-11-24, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff7e22083386, moduleTitle=J Clin Oncol：神经激肽-1受体拮抗剂fosnetupitant (FosNTP)对比fosaprepitant (FosAPR)预防高致吐性化疗引起的恶心和呕吐的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff7e22083386)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

(审核中...)

前往app查看评论内容

全文收起 #原发性醛固酮增多症#(PA)是一种常见但常被忽视的高血压病因，其特征是#肾素#不依赖自主#醛固酮#分泌过多。大约30%的PA患者醛固酮分泌过多，即以肾上腺为主。在这些患者中，#单侧肾上腺切除#术被认为是治疗的选择。对于双侧疾病的患者，建议使用矿物皮质激素受体#拮抗剂#(MRA)进行药物治疗。

Hypertension：原发性醛固酮增多症患者的死亡率

2023-10-24发表于上海

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

常用血管紧张素受体拮抗剂解析

2022-09-08

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

PRS：半胱氨酸白三烯信号拮抗剂孟鲁司特不利于烧伤创面愈合

2022-09-04

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Stroke：脑静脉血栓形成患者直接口服抗凝剂与维生素K拮抗剂的疗效比较

2022-08-10

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

盘点多巴胺受体拮抗剂在精神分裂症中的临床应用

2022-07-27

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Eur Rev Med Pharmacol Sci：老年人创伤性脑损伤前服用VK拮抗剂或DOACs是否会影响其结局？

2022-07-23

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Lancet rheumatology：儿童多系统炎症综合征中针对白细胞介素-1受体拮抗剂的自身抗体：一项多中心、回顾性、队列研究

2022-05-27

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Cell：揭示使用药用大麻增加心脏病风险，CB1拮抗剂染料木黄酮有望来拯救

2022-05-26

仁心济世 (审核中...)

前往app查看评论内容

#拮抗剂#

JACC：盐皮质激素受体拮抗剂对恩格列净治疗射血分数保留的心衰患者的效果的影响

2022-03-30

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Neurology：神经结节病预后与病变定位相关，肿瘤坏死因子α拮抗剂优于单独使用皮质类固醇

2022-03-19

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

失眠患者的福音，CHMP推荐双效食欲素受体拮抗剂Quviviq

2022-03-11

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Eur Respir J：白细胞介素 6 受体拮抗剂对成年重症 COVID-19 肺炎患者的影响

2022-03-03

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JAHA：绝经后妇女组胺H2受体拮抗剂与心力衰竭风险之间的关系

2022-02-25

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

亚太III期BHV3000-310研究显示，口服降钙素基因相关肽（CGRP）受体拮抗剂，可快速和持久地缓解偏头痛

2022-02-17

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

拜耳放弃研发P2X3受体拮抗剂eliapixant

2022-02-07

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

CGH: 维多珠单抗与肿瘤坏死因子拮抗剂在炎症性肠病患者中造成严重感染风险的差异比较

2022-01-28

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JACL:TRPV1拮抗剂Asivatrep用于局部治疗特应性皮炎

2021-12-24

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

新药进展 | 治疗慢性咳嗽！中国生物制药自研1类新药P2X3受体拮抗剂获批临床

2021-12-24

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

NEJM：依度沙班对比维生素K拮抗剂治疗TAVR后房颤的疗效比较

2021-12-03

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

J Clin Oncol：神经激肽-1受体拮抗剂fosnetupitant (FosNTP)对比fosaprepitant (FosAPR)预防高致吐性化疗引起的恶心和呕吐的有效性和安全性

2021-11-24

科室
- - 订阅+
  - 更多科室
工具
服务